Skip to main content
. 2023 May 9;12(5):971–984. doi: 10.21037/tlcr-22-818

Figure 1.

Figure 1

Swimmer plot for all included advanced NSCLC patients treated with a least one cycle of pembrolizumab. Each bar represents an individual patient. PD, progressive disease; NSCLC, non-small cell lung cancer.